We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
The University of Edinburgh and FUJIFILM Diosynth Biotechnologies UK (FDB) are leading an £8.7 million, five-year research collaboration to develop more cost-effective ways to make modern antibody-based medicines.
Researchers have discovered that a class of drugs being developed to treat cancer can also help prompt liver regeneration after severe injury, raising hopes of a new treatment that might help some patients avoid a liver transplant.